annual cash & cash equivalents:
$677.50M-$299.32M(-30.64%)Summary
- As of today (September 17, 2025), RDY annual cash & cash equivalents is $677.50 million, with the most recent change of -$299.32 million (-30.64%) on March 31, 2025.
- During the last 3 years, RDY annual cash & cash equivalents has risen by +$92.02 million (+15.72%).
- RDY annual cash & cash equivalents is now -30.64% below its all-time high of $976.83 million, reached on March 31, 2024.
Performance
RDY Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$777.61M+$100.11M(+14.78%)Summary
- As of today (September 17, 2025), RDY quarterly cash & cash equivalents is $777.61 million, with the most recent change of +$100.11 million (+14.78%) on June 30, 2025.
- Over the past year, RDY quarterly cash & cash equivalents has dropped by -$357.16 million (-31.47%).
- RDY quarterly cash & cash equivalents is now -31.47% below its all-time high of $1.13 billion, reached on June 30, 2024.
Performance
RDY quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RDY Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.6% | -31.5% |
| 3 y3 years | +15.7% | +77.4% |
| 5 y5 years | +99.1% | +112.0% |
RDY Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.6% | +15.7% | -31.5% | +129.4% |
| 5 y | 5-year | -30.6% | +99.1% | -31.5% | +258.4% |
| alltime | all time | -30.6% | >+9999.0% | -31.5% | >+9999.0% |
RDY Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $777.61M(+14.8%) |
| Mar 2025 | $677.50M(-30.6%) | $677.50M(-3.2%) |
| Dec 2024 | - | $699.91M(-7.0%) |
| Sep 2024 | - | $752.66M(-33.7%) |
| Jun 2024 | - | $1.13B(+16.2%) |
| Mar 2024 | $976.83M(+29.9%) | $976.83M(+12.0%) |
| Dec 2023 | - | $871.85M(+6.6%) |
| Sep 2023 | - | $818.02M(+11.4%) |
| Jun 2023 | - | $734.55M(-2.3%) |
| Mar 2023 | $751.95M(+28.4%) | $751.95M(+28.3%) |
| Dec 2022 | - | $586.24M(+73.0%) |
| Sep 2022 | - | $338.96M(-22.7%) |
| Jun 2022 | - | $438.39M(-25.1%) |
| Mar 2022 | $585.48M(+23.8%) | $585.48M(+23.6%) |
| Dec 2021 | - | $473.53M(+43.0%) |
| Sep 2021 | - | $331.16M(-13.6%) |
| Jun 2021 | - | $383.41M(-18.9%) |
| Mar 2021 | $472.87M(+39.0%) | $472.87M(+118.0%) |
| Dec 2020 | - | $216.94M(-36.1%) |
| Sep 2020 | - | $339.43M(-7.4%) |
| Jun 2020 | - | $366.75M(+7.8%) |
| Mar 2020 | $340.25M(-4.8%) | $340.25M(+23.0%) |
| Dec 2019 | - | $276.68M(-31.3%) |
| Sep 2019 | - | $402.89M(+4.2%) |
| Jun 2019 | - | $386.73M(+8.2%) |
| Mar 2019 | $357.37M(+10.6%) | $357.37M(-1.8%) |
| Dec 2018 | - | $363.80M(+33.7%) |
| Sep 2018 | - | $272.20M(+17.6%) |
| Jun 2018 | - | $231.56M(-28.3%) |
| Mar 2018 | $323.07M(+14.0%) | $323.07M(-7.6%) |
| Dec 2017 | - | $349.75M(+34.7%) |
| Sep 2017 | - | $259.72M(+15.2%) |
| Jun 2017 | - | $225.44M(-20.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | $283.33M(-53.2%) | $283.33M(-5.0%) |
| Dec 2016 | - | $298.16M(-7.6%) |
| Sep 2016 | - | $322.76M(-15.1%) |
| Jun 2016 | - | $380.37M(-37.2%) |
| Mar 2016 | $605.99M(-6.3%) | $605.99M(+16.2%) |
| Sep 2015 | - | $521.71M(-19.3%) |
| Mar 2015 | $646.41M(+13.3%) | $646.41M(+36.8%) |
| Sep 2014 | - | $472.41M(-17.2%) |
| Mar 2014 | $570.63M(+37.0%) | $570.63M(+31.4%) |
| Sep 2013 | - | $434.41M(+4.3%) |
| Mar 2013 | $416.67M(+16.9%) | $416.67M(+6.5%) |
| Sep 2012 | - | $391.36M(+9.8%) |
| Mar 2012 | $356.46M(+142.9%) | $356.46M(+85.2%) |
| Sep 2011 | - | $192.43M(+31.1%) |
| Mar 2011 | $146.76M(-0.2%) | $146.76M(+6.4%) |
| Sep 2010 | - | $137.87M(-6.2%) |
| Mar 2010 | $146.98M(+32.6%) | $146.98M(+32.6%) |
| Mar 2009 | $110.83M(-40.4%) | $110.83M(-40.4%) |
| Mar 2008 | $185.80M(-56.6%) | $185.80M(-56.6%) |
| Mar 2007 | $428.22M(+94.8%) | $428.22M(+94.8%) |
| Mar 2006 | $219.83M(+2.6%) | $219.83M(+2.6%) |
| Mar 2005 | $214.23M(+106.9%) | $214.23M(+106.9%) |
| Mar 2004 | $103.53M(-32.5%) | $103.53M(-32.5%) |
| Mar 2003 | $153.41M(+46.1%) | $153.41M(+46.1%) |
| Mar 2002 | $105.03M(+2420.0%) | $105.03M(+2420.0%) |
| Mar 2001 | $4.17M(-17.0%) | - |
| Mar 2001 | - | $4.17M |
| Mar 2000 | $5.02M(+12.9%) | - |
| Mar 1999 | $4.45M(+22.4%) | - |
| Mar 1998 | $3.63M(+231.2%) | - |
| Mar 1997 | $1.10M(-29.5%) | - |
| Mar 1996 | $1.56M(-1.0%) | - |
| Mar 1995 | $1.57M | - |
FAQ
- What is Dr. Reddy's Laboratories Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Dr. Reddy's Laboratories Limited?
- What is Dr. Reddy's Laboratories Limited annual cash & cash equivalents year-on-year change?
- What is Dr. Reddy's Laboratories Limited quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Dr. Reddy's Laboratories Limited?
- What is Dr. Reddy's Laboratories Limited quarterly cash & cash equivalents year-on-year change?
What is Dr. Reddy's Laboratories Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of RDY is $677.50M
What is the all time high annual cash & cash equivalents for Dr. Reddy's Laboratories Limited?
Dr. Reddy's Laboratories Limited all-time high annual cash & cash equivalents is $976.83M
What is Dr. Reddy's Laboratories Limited annual cash & cash equivalents year-on-year change?
Over the past year, RDY annual cash & cash equivalents has changed by -$299.32M (-30.64%)
What is Dr. Reddy's Laboratories Limited quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of RDY is $777.61M
What is the all time high quarterly cash & cash equivalents for Dr. Reddy's Laboratories Limited?
Dr. Reddy's Laboratories Limited all-time high quarterly cash & cash equivalents is $1.13B
What is Dr. Reddy's Laboratories Limited quarterly cash & cash equivalents year-on-year change?
Over the past year, RDY quarterly cash & cash equivalents has changed by -$357.16M (-31.47%)